Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lemonaid Health vs Levers Health

Lemonaid Health
Graded #488

Lower grade

vs+2.0999999999999943
Levers Health
Graded #468

Higher grade

The verdict

Levers Health takes it — 53.3/100 to 51.2/100.

Levers Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Levers Health (Levers Health LLC) offers compounded semaglutide (from $247/mo) and tirzepatide (from $296/mo), plus low-dose/microdose GLP-1 for longevity.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLevers Health +14
20
34
Dose & formulationLevers Health +2
52
54
Clinical oversightLemonaid Health +3
74
71
Labs & monitoringEven
53
53
FulfillmentLemonaid Health +19
81
62
Contract termsLevers Health +14
41
55
Lemonaid Health · left barLevers Health · right bar

The numbers

MetricLemonaid HealthLevers Health
WeighScore51.2/10053.3/100
GradeCC
Scorecard rank#488#468
Semaglutide$348/mo (starting dose, plus a separate fee, compounded)$247/mo (1.25 mg dose, compounded)
TirzepatideNot disclosed$296/mo (5 mg dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Lemonaid Health

Graded #488 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Levers Health

Graded #468 · C

Strengths

  • Named LLC entity
  • Microdose GLP-1 option marketed for longevity
  • Both semaglutide and tirzepatide available

Where it loses points

  • No LegitScript or PCAB accreditation
  • No physical address disclosed
  • State availability not disclosed
  • FAQ and terms pages return 404
  • Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard